Pediatrix Medical (MD) Cash from Financing Activities (2009 - 2026)

Pediatrix Medical (MD) has 18 years of Cash from Financing Activities data on file, last reported at -$27.6 million in Q1 2026.

• Cash from Financing Activities for Q1 2026 came in at -$27.6 million, down 357.91% year-over-year; the trailing twelve-month figure through Mar 2026 was -$129.1 million (down 33.47% YoY), and the FY2025 annual result was -$107.5 million, down 642.11% from the prior year.
• Cash from Financing Activities rose to -$27.6 million in Q1 2026 per MD's latest filing, from -$68.6 million in the prior quarter.
• Over five years, Cash from Financing Activities peaked at $108.6 million in Q1 2023 and troughed at -$256.5 million in Q1 2022.
• A 5-year average of -$39.0 million and a median of -$28.6 million in 2025 frame the typical range for Cash from Financing Activities.
• The sharpest annual moves came in 2022 and 2023: Cash from Financing Activities tumbled 63000.76% in 2022, then soared 142.33% in 2023.
• A 5-year view of Cash from Financing Activities shows it stood at -$86.3 million in 2022, then jumped by 94.5% to -$4.7 million in 2023, then decreased by 4.55% to -$5.0 million in 2024, then sank by 1282.99% to -$68.6 million in 2025, then soared by 59.74% to -$27.6 million in 2026.
• Business Quant data shows MD's Cash from Financing Activities at -$27.6 million in Q1 2026, -$68.6 million in Q4 2025, and -$28.6 million in Q3 2025.